Armata Pharmaceuticals Stock (AMEX: ARMP) stock price, news, charts, stock research, profile.
Open | $3.110 |
Close | - |
Volume / Avg. | 1.959K / 16.010K |
Day Range | 3.110 - 3.361 |
52 Wk Range | 1.070 - 5.257 |
Market Cap | $116.418M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 57 |
Short Interest | 0.09% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Armata Pharmaceuticals (AMEX: ARMP) through any online brokerage.
Other companies in Armata Pharmaceuticals’s space includes: Anixa Biosciences (NASDAQ:ANIX), Curis (NASDAQ:CRIS), Cellectar Biosciences (NASDAQ:CLRB), FibroGen (NASDAQ:FGEN) and Elicio Therapeutics (NASDAQ:ELTX).
The latest price target for Armata Pharmaceuticals (AMEX: ARMP) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 7.00 expecting ARMP to rise to within 12 months (a possible 117.39% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Armata Pharmaceuticals (AMEX: ARMP) is $3.22 last updated Today at May 13, 2024 at 10:35 AM EDT.
There are no upcoming dividends for Armata Pharmaceuticals.
Armata Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Armata Pharmaceuticals.
Armata Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.